Literature DB >> 11641525

Focal organizing pneumonia: CT and pathologic findings.

P S Yang1, K S Lee, J Han, E A Kim, T S Kim, I W Choo.   

Abstract

The purpose of this study was to describe the CT findings of focal organizing pneumonia and to compare the findings with pathology. CT findings of histologically proven focal organizing pneumonias in 26 consecutive patients were analyzed. In 17 patients who had undergone surgical resections, the findings were correlated with pathology. Focal organizing pneumonias appeared as a nodule (n= 13) or a mass (n=13), ranging from 9 mm to 66 mm in diameter. Ground-glass opacity was seen in 6/13 (46%) nodules and 6.5/13 (50%) masses (k=.48) with an extent ranging from 5% to 75% (mean, 16%). In 4/26 (15%) patients, the extent was more than 50% of the lesion. They showed smooth (n=4), lobulated (n=8), spiculated (n=1), or lobulated and spiculated margin (n=13). On correlative analysis, nodule or mass on CT consisted histologically of intraalveolar exudate or microabscess, chronic inflammatory cell infiltration, fibrotic nodules, and polypoid granulation tissue in the alveolar or bronchiolar spaces. Ground-glass opacity consisted of interstitial fibrosis and chronic inflammatory cell infiltration and intraalveolar polypoid granulation tissue. Focal organizing pneumonia may simulate a lung cancer with variable appearances on CT and the findings reflect underlying histopathology of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11641525      PMCID: PMC3057585          DOI: 10.3346/jkms.2001.16.5.573

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  9 in total

1.  Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant.

Authors:  L Fan; S-Y Liu; Q-C Li; H Yu; X-S Xiao
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

2.  Organizing Pneumonia as a Histopathological Term.

Authors:  Fatma Tokgöz Akyıl; Meltem Ağca; Aysun Mısırlıoğlu; Ayşe Alp Arsev; Mustafa Akyıl; Tülin Sevim
Journal:  Turk Thorac J       Date:  2017-07-01

3.  Quantitative MDCT analysis of pulmonary solid nodules using three parameters.

Authors:  Naoki Kutuya; Yutaka Ozaki; Yoshihisa Kurosaki
Journal:  Radiat Med       Date:  2008-09-04

4.  Clinicopathological findings of focal organizing pneumonia: a retrospective study of 37 cases.

Authors:  Zhen Huo; Ruie Feng; Xinlun Tian; Haibo Zhang; Li Huo; Hongrui Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Computed Tomographic Appearance of Organizing Pneumonia in an Oncologic Patient Population.

Authors:  Niamh M Long; Andrew J Plodkowski; Rachel Schor-Bardach; Alexander I Geyer; Junting Zheng; Chaya S Moskowitz; Michelle S Ginsberg
Journal:  J Comput Assist Tomogr       Date:  2017 May/Jun       Impact factor: 1.826

6.  Visual discrimination of screen-detected persistent from transient subsolid nodules: An observer study.

Authors:  Kaman Chung; Francesco Ciompi; Ernst T Scholten; Jin Mo Goo; Mathias Prokop; Colin Jacobs; Bram van Ginneken; Cornelia M Schaefer-Prokop
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

7.  Lung Masses of Unusual Histologies Mimicking Malignancy: Flurodeoxyglucose Positron Emission Tomography-Computed Tomography Appearance.

Authors:  Boon Mathew; Nilendu C Purandare; Sneha Shah; Ameya Puranik; Archi Agrawal; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2019 Oct-Dec

8.  Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules.

Authors:  Kaman Chung; Colin Jacobs; Ernst T Scholten; Onno M Mets; Irma Dekker; Mathias Prokop; Bram van Ginneken; Cornelia M Schaefer-Prokop
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

9.  Cocaine-induced pulmonary complications: A diagnosis of waiting and watching.

Authors:  Rohit Munagala; Varsha Chiruvella; Darko Pucar; Jayanth Keshavamurthy
Journal:  Lung India       Date:  2021 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.